X-ray screening identifies active site and allosteric inhibitors of SARS-CoV-2 main protease.

S, Günther; PYA, Reinke; Y, Fernández-García; J, Lieske; TJ, Lane; HM, Ginn; FHM, Koua; C, Ehrt; W, Ewert; D, Oberthuer; O, Yefanov; S, Meier; K, Lorenzen; B, Krichel; JD, Kopicki; L, Gelisio; W, Brehm; I, Dunkel; B, Seychell; H, Gieseler; B, Norton-Baker; B, Escudero-Pérez; M, Domaracky; S, Saouane; A, Tolstikova; TA, White; A, Hänle; M, Groessler; H, Fleckenstein; F, Trost; M, Galchenkova; Y, Gevorkov; C, Li; S, Awel; A, Peck; M, Barthelmess; F, Schlünzen; Xavier P, Lourdu; N, Werner; H, Andaleeb; N, Ullah; S, Falke; V, Srinivasan; BA, França; M, Schwinzer; H, Brognaro; C, Rogers; D, Melo; JI, Zaitseva-Kinneberg; J, Knoska; GE, Peña-Murillo; AR, Mashhour; V, Hennicke; P, Fischer; J, Hakanpää; J, Meyer; P, Gribbon; B, Ellinger; M, Kuzikov; M, Wolf; AR, Beccari; G, Bourenkov; Stetten D, von; G, Pompidor; I, Bento; S, Panneerselvam; I, Karpics; TR, Schneider; MM, Garcia-Alai; S, Niebling; C, Günther; C, Schmidt; R, Schubert; H, Han; J, Boger; DCF, Monteiro; L, Zhang; X, Sun; J, Pletzer-Zelgert; J, Wollenhaupt; CG, Feiler; MS, Weiss; EC, Schulz; P, Mehrabi; K, Karničar; A, Usenik; J, Loboda; H, Tidow; A, Chari; R, Hilgenfeld; C, Uetrecht; R, Cox; A, Zaliani; T, Beck; M, Rarey; S, Günther; D, Turk; W, Hinrichs; HN, Chapman; AR, Pearson; C, Betzel; A, Meents

doi:10.1126/science.abf7945

Public

X-ray screening identifies active site and allosteric inhibitors of SARS-CoV-2 main protease.

Shared by NobleBlocks on Apr 2, 2021 • 12:00 AM UTC

Authors:

Günther S

Reinke PYA

Fernández-García Y

Abstract

The coronavirus disease (COVID-19) caused by SARS-CoV-2 is creating tremendous human suffering. To date, no effective drug is available to directly treat the disease. In a search for a drug against COVID-19, we have performed a high-throughput x-ray crystallographic screen of two repurposing drug li...

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!